Literature DB >> 23079632

Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone.

S Yousuf1, F Atif, I Sayeed, J Wang, D G Stein.   

Abstract

We investigated the effect of delayed, prolonged systemic inflammation on stroke outcomes and progesterone (P4) neuroprotection in middle-aged rats. After transient middle cerebral artery occlusion/reperfusion (MCAO) surgery, rats received P4 (8 or 16 mg/kg) or vehicle injections at 2h, 6h and every 24h until day 7 post-occlusion. At 24h post-injury systemic inflammation was induced by giving three doses of lipopolysaccharide (LPS; 50 μg/kg, at 4h intervals) to model post-stroke infections. We measured serum brain-derived neurotrophic factor (BDNF), pro-inflammatory cytokines, and behavioral parameters at multiple times. Serum BDNF levels decreased more in the vehicle+LPS group compared to vehicle-alone at 3 and 7 days post-injury (P<0.05). Vehicle-alone showed a significant increase in interleukin-1β, interleukin-6, and tumor necrosis factor alpha levels at different times following stroke and these levels were further elevated in the vehicle+LPS group. P4 at both doses produced a significant (P<0.05) decline in cytokine levels compared to vehicle and vehicle+LPS. P4 restored BDNF levels at 3 and 7 days post-stroke (P<0.05). Behavioral assessment (rotarod, grip strength, sensory neglect and locomotor activity tests) at 3, 5 and 7 days post-stroke revealed that the vehicle group had significant (P<0.05) deficits in all tests compared to intact controls, and performance was worse in the vehicle+LPS group. P4 at both doses produced significant functional improvement on all tests. Systemic inflammation did not show an additive effect on infarct volume but P4 at both doses showed significant infarct reduction. We suggest that post-stroke infection exacerbates stroke outcomes and P4 exerts neuroprotective/modulatory effects through its systemic anti-inflammatory and BDNF regulatory actions.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23079632      PMCID: PMC3586989          DOI: 10.1016/j.neuroscience.2012.10.017

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  87 in total

1.  Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.

Authors:  N R Bhat; P Zhang; J C Lee; E L Hogan
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

2.  Delayed postischemic hyperthermia in awake rats worsens the histopathological outcome of transient focal cerebral ischemia.

Authors:  Y Kim; R Busto; W D Dietrich; S Kraydieh; M D Ginsberg
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

3.  Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion.

Authors:  K Abe; T Hayashi
Journal:  Brain Res       Date:  1997-11-21       Impact factor: 3.252

4.  Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice.

Authors:  Claire L Gibson; Sean P Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2004-07       Impact factor: 6.200

5.  Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death.

Authors:  K M Boje; P K Arora
Journal:  Brain Res       Date:  1992-08-07       Impact factor: 3.252

6.  BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Stuart Maudsley; Bronwen Martin
Journal:  Trends Neurosci       Date:  2004-10       Impact factor: 13.837

7.  Progesterone up-regulates neuronal brain-derived neurotrophic factor expression in the injured spinal cord.

Authors:  S L González; F Labombarda; M C González Deniselle; R Guennoun; M Schumacher; A F De Nicola
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

8.  Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages.

Authors:  L Miller; E W Alley; W J Murphy; S W Russell; J S Hunt
Journal:  J Leukoc Biol       Date:  1996-03       Impact factor: 4.962

9.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

10.  Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.

Authors:  Craig J Smith; Hedley C A Emsley; Carole M Gavin; Rachel F Georgiou; Andy Vail; Elisa M Barberan; Gregory J del Zoppo; John M Hallenbeck; Nancy J Rothwell; Stephen J Hopkins; Pippa J Tyrrell
Journal:  BMC Neurol       Date:  2004-01-15       Impact factor: 2.474

View more
  25 in total

1.  Progesterone in transient ischemic stroke: a dose-response study.

Authors:  Seema Yousuf; Fahim Atif; Iqbal Sayeed; Huiling Tang; Donald G Stein
Journal:  Psychopharmacology (Berl)       Date:  2014-04-22       Impact factor: 4.530

2.  Let-7i inhibition enhances progesterone-induced functional recovery in a mouse model of ischemia.

Authors:  Trinh Nguyen; Chang Su; Meharvan Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-20       Impact factor: 11.205

3.  Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats.

Authors:  Bushra Wali; Tauheed Ishrat; Donald G Stein; Iqbal Sayeed
Journal:  Behav Brain Res       Date:  2016-02-26       Impact factor: 3.332

4.  Infections Up to 76 Days After Stroke Increase Disability and Death.

Authors:  Annastazia E Learoyd; Lisa Woodhouse; Laurence Shaw; Nikola Sprigg; Daniel Bereczki; Eivind Berge; Valeria Caso; Hanne Christensen; Ronan Collins; Anna Czlonkowska; Anwar El Etribi; Tracy D Farr; John Gommans; Ann-Charlotte Laska; George Ntaios; Serefnur Ozturk; Stuart J Pocock; Kameshwar Prasad; Joanna M Wardlaw; Kevin C Fone; Philip M Bath; Rebecca C Trueman
Journal:  Transl Stroke Res       Date:  2017-07-27       Impact factor: 6.829

5.  Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.

Authors:  Yu Ri Kim; Ha Neui Kim; Ki Whan Hong; Hwa Kyoung Shin; Byung Tae Choi
Journal:  Psychopharmacology (Berl)       Date:  2015-12-21       Impact factor: 4.530

6.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

7.  Progesterone treatment shows greater protection in brain vs. retina in a rat model of middle cerebral artery occlusion: Progesterone receptor levels may play an important role.

Authors:  Rachael S Allen; Iqbal Sayeed; Yuliya Oumarbaeva; Katherine C Morrison; Paul H Choi; Machelle T Pardue; Donald G Stein
Journal:  Restor Neurol Neurosci       Date:  2016-11-22       Impact factor: 2.406

8.  Evaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.

Authors:  Ryan P Lange; Allen Everett; Pratima Dulloor; Frederick K Korley; Chetan Bettegowda; Cherie Blair; Stuart A Grossman; Matthias Holdhoff
Journal:  Cancer Invest       Date:  2014-07-14       Impact factor: 2.176

Review 9.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

10.  Lipopolysaccharide worsens the prognosis of experimental cerebral ischemia via interferon gamma-induced protein 10 recruit in the acute stage.

Authors:  Ping Wang; Jiaqi Zhang; Feifei Guo; Shuang Wang; Yi Zhang; Defeng Li; Haiyu Xu; Hongjun Yang
Journal:  BMC Neurosci       Date:  2019-12-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.